Clinical Trial Results
Search
Dr. Jan Griffin and Dr. C. Michael Gibson discuss: Long-term benefits with acoramidis on Kansas City cardiomyopathy questionnaire-overall summary (KCCQ-OS) score and serum transthyretin levels in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.
Dr. Will Gibson and Dr. C. Michael Gibson discuss how p53 was once considered an undruggable target for cancer therapy.
A new article in the NEJM raises hope that there may be a path forward. Dr. Will Gibson, an oncologist at […]
